Optimal delivery of male breast cancer follow-up care: improving outcomes

References

• SiegelRDesantisCJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
   PubMed Web of Science ®Google Scholar
• GiordanoSHCohenDSBuzdarAUPerkinsGHortobagyiGNBreast carcinoma in men: a population-based studyCancer20041011515715221988
   PubMed Web of Science ®Google Scholar
• SocietyACCancer Facts and Figures 2015AtlantaAmerican Cancer Society2015
   Google Scholar
• OttiniLMasalaGD’AmicoCBRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in ItalyCancer Res200363234234712543786
   PubMed Web of Science ®Google Scholar
• BrintonLARichessonDAGierachGLProspective evaluation of risk factors for male breast cancerJ Natl Cancer Inst2008100201477148118840816
   PubMedGoogle Scholar
• KwiatkowskaETeresiakMFilasVKarczewskaABreborowiczDMackiewiczABRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patientsClin Cancer Res20039124452445914555518
   PubMed Web of Science ®Google Scholar
• FriedmanLSGaytherSAKurosakiTMutation analysis of BRCA1 and BRCA2 in a male breast cancer populationAm J Hum Genet19976023133199012404
   PubMed Web of Science ®Google Scholar
• Meijers-HeijboerHvan den OuwelandAKlijnJWasielewskiMCHEK2-Breast Cancer ConsortiumLow-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutationsNat Genet2002311555911967536
   PubMed Web of Science ®Google Scholar
• YoungIEKurianKMAnninkCA polymorphism in the CYP17 gene is associated with male breast cancerBr J Cancer199981114114310487625
   PubMed Web of Science ®Google Scholar
• MesterJEngCCowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndromeJ Surg Oncol2015111112513025132236
   PubMed Web of Science ®Google Scholar
• FackenthalJDMarshDJRichardsonALMale breast cancer in Cowden syndrome patients with germline PTEN mutationsJ Med Genet200138315916411238682
   PubMed Web of Science ®Google Scholar
• KuroishiTHiroseKTajimaKTominagaSDescriptive epidemiology of male breast cancer in JapanBreast Cancer199742778311091581
   PubMedGoogle Scholar
• RonEIkedaTPrestonDLTokuokaSMale breast cancer incidence among atomic bomb survivorsJ Natl Cancer Inst200597860360515840883
   PubMedGoogle Scholar
• ParkSKimJHKooJParkBWLeeKSClinicopathological characteristics of male breast cancerYonsei Med J200849697898619108022
   PubMed Web of Science ®Google Scholar
• MiaoHVerkooijenHMChiaKSIncidence and outcome of male breast cancer: an international population-based studyJ Clin Oncol201129334381438621969512
   PubMed Web of Science ®Google Scholar
• EwertzMHolmbergLTretliSPedersenBVKristensenARisk factors for male breast cancer – a case-control study from ScandinaviaActa Oncol200140446747111504305
   PubMed Web of Science ®Google Scholar
• HultbornRHansonCKöpfIVerbienéIWarnhammarEWeimarckAPrevalence of Klinefelter’s syndrome in male breast cancer patientsAnticancer Res1997176D429342979494523
   PubMed Web of Science ®Google Scholar
• MedrasMFilusAJozkowPWinowskiJSicinska-WernerTBreast cancer and long-term hormonal treatment of male hypogonadismBreast Cancer Res Treat200696326326516418796
   PubMed Web of Science ®Google Scholar
• CardosoFBartlettJGiordanoSCharacterization of male breast cancer: First results of the EORTC10085/TBCRC/BIG/NABCG International Male BC Program2014 San Antonio Breast Cancer Symposium2014European Organization for Research and Treatment of CancerSan Antonio, TX
   Google Scholar
• GnerlichJLDeshpandeADJeffeDBSeelamSKimbuendeEMargenthalerJAPoorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migrationAnn Surg Oncol20111871837184421484520
   PubMed Web of Science ®Google Scholar
• HowladerNNooneAMKrapchoMSEER Cancer Statistics Review, 1975–2011Bethesda MarylandNational Cancer Institute2014
   Google Scholar
• RuddyKJWinerEPMale breast cancer: risk factors, biology, diagnosis, treatment, and survivorshipAnn Oncol20132461434144323425944
   PubMed Web of Science ®Google Scholar
• KilukJVLeeMCParkCKMale breast cancer: management and follow-up recommendationsBreast J201117550350921883641
   PubMed Web of Science ®Google Scholar
• SascoAJLowenfelsABPasker-de JongPReview article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factorsInt J Cancer19935345385498436428
   PubMed Web of Science ®Google Scholar
• GrenaderTGoldbergAShavitLSecond cancers in patients with male breast cancer: a literature reviewJ Cancer Surviv200822737818648975
   PubMedGoogle Scholar
• FentimanISFourquetAHortobagyiGNMale breast cancerLancet2006367951059560416488803
   PubMed Web of Science ®Google Scholar
• AuvinenACurtisRERonERisk of subsequent cancer following breast cancer in menJ Natl Cancer Inst200294171330133212208898
   PubMedGoogle Scholar
• DongCHemminkiKSecond primary breast cancer in menBreast Cancer Res Treat200166217117211437104
   PubMed Web of Science ®Google Scholar
• CutuliBLe-NirCCSerinDMale breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 casesCrit Rev Oncol Hematol201073324625419442535
   PubMed Web of Science ®Google Scholar
• MasciGCarusoMCarusoFClinicopathological and immunohistochemical characteristics in male breast cancer: a retrospective case seriesOncologist201520658659225948676
   PubMed Web of Science ®Google Scholar
• AndersonDEBadziochMDFamilial breast cancer risks. Effects of prostate and other cancersCancer19937211141198508396
   PubMed Web of Science ®Google Scholar
• AndersonDEBadziochMDBreast cancer risks in relatives of male breast cancer patientsJ Natl Cancer Inst19928414111411171619685
   PubMedGoogle Scholar
• ThellenbergCMalmerBTavelinBGrönbergHSecond primary cancers in men with prostate cancer: an increased risk of male breast cancerJ Urol200316941345134812629357
   PubMed Web of Science ®Google Scholar
• HemminkiKScéloGBoffettaPSecond primary malignancies in patients with male breast cancerBr J Cancer20059271288129215798766
   PubMed Web of Science ®Google Scholar
• LeeUJJonesJSIncidence of prostate cancer in male breast cancer patients: a risk factor for prostate cancer screeningProstate Cancer Prostatic Dis2009121525618504455
   PubMed Web of Science ®Google Scholar
• Network NCCBreast Cancer. NCCN Clinical Practice Guidelines in Oncology2015 Available from: http://www.nccn.org/professionals/physician_gls/pdf/breast.pdfAccessed June 26, 2015
   Google Scholar
• BashamVMLipscombeJMWardJMBRCA1 and BRCA2 mutations in a population-based study of male breast cancerBreast Cancer Res200241R211879560
   PubMed Web of Science ®Google Scholar
• ThorlaciusSSigurdssonSBjarnadottirHStudy of a single BRCA2 mutation with high carrier frequency in a small populationAm J Hum Genet1997605107910849150155
   PubMed Web of Science ®Google Scholar
• SverdlovRSBarshackIBar SadeRBGenetic analyses of male breast cancer in IsraelGenet Test20004331331711142766
   PubMedGoogle Scholar
• GiordanoSHA review of the diagnosis and management of male breast cancerOncologist200510747147916079314
   PubMed Web of Science ®Google Scholar
• BerryDAIversenESJrGudbjartssonDFBRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genesJ Clin Oncol200220112701271212039933
   PubMed Web of Science ®Google Scholar
• EuhusDMSmithKCRobinsonLPretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPROJ Natl Cancer Inst2002941184485112048272
   PubMedGoogle Scholar
• HuoDSenieRTDalyMPrediction of BRCA mutations using the BRCAPRO model in clinic-based African American, Hispanic, and other minority families in the United StatesJ Clin Oncol20092781184119019188678
   PubMed Web of Science ®Google Scholar
• MitriZIJacksonMGarbyCBRCAPRO 6.0 model validation in male patients presenting for BRCA testingOncologist201520659359725948675
   PubMed Web of Science ®Google Scholar
• NeuhausenSDunningASteeleLRole of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancersInt J Cancer2004108347747814648718
   PubMed Web of Science ®Google Scholar
• BoydJRheiEFedericiMGMale breast cancer in the hereditary nonpolyposis colorectal cancer syndromeBreast Cancer Res Treat1999531879110206076
   PubMed Web of Science ®Google Scholar
• Network NCCGenetic/Familial High-Risk Assessment: Breast and OvarianNCCN Clinical Practice Guidelines in Oncology2015 Available from: http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdfAccessed June 20, 2015
   Google Scholar
• AnelliTFAnelliATranKNLebwohlDEBorgenPITamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patientsCancer199474174778004585
   PubMed Web of Science ®Google Scholar
• VisramHKanjiFDentSFEndocrine therapy for male breast cancer: rates of toxicity and adherenceCurr Oncol2010175172120975874
   PubMed Web of Science ®Google Scholar
• PemmarajuNMunsellMFHortobagyiGNGiordanoSHRetrospective review of male breast cancer patients: analysis of tamoxifen-related side-effectsAnn Oncol20122361471147422085764
   PubMed Web of Science ®Google Scholar
• BeckerTLipscombeLNarodSSimmonsCAndersonGMRochonPASystematic review of bone health in older women treated with aromatase inhibitors for early-stage breast cancerJ Am Geriatr Soc20126091761176722985145
   PubMed Web of Science ®Google Scholar
• BauerMBryceJHadjiPAromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancerBreast Cancer201249110124367197
   PubMedGoogle Scholar
• EastellRAdamsJEColemanREEffect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230J Clin Oncol20082671051105718309940
   PubMed Web of Science ®Google Scholar
• ColemanREBanksLMGirgisSIIntergroup Exemestane Study GroupSkeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled studyLancet Oncol20078211912717267326
   PubMed Web of Science ®Google Scholar
• HowellACuzickJBaumMATAC Trialists’ GroupResults of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancerLancet20053659453606215639680
   PubMed Web of Science ®Google Scholar
• GrossmannMHamiltonEJGilfillanCBoltonDJoonDLZajacJDBone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapyMed J Aust2011194630130621426285
   PubMed Web of Science ®Google Scholar
• SharifiNGulleyJLDahutWLAndrogen deprivation therapy for prostate cancerJAMA2005294223824416014598
   PubMed Web of Science ®Google Scholar
• SmithMRAndrogen deprivation therapy for prostate cancer: new concepts and concernsCurr Opin Endocrinol Diabetes Obes200714324725417940447
   PubMedGoogle Scholar
• GreenspanSLApproach to the prostate cancer patient with bone diseaseJ Clin Endocrinol Metab20089312718178905
   PubMed Web of Science ®Google Scholar
• DiamondTHHiganoCSSmithMRGuiseTASingerFROsteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapiesCancer2004100589289914983482
   PubMed Web of Science ®Google Scholar
• HiganoCSAndrogen-deprivation-therapy-induced fractures in men with nonmetastatic prostate cancer: what do we really know?Nat Clin Pract Urol200851243418185511
   PubMedGoogle Scholar
• HamiltonEJGhasem-ZadehAGianattiEStructural decay of bone microarchitecture in men with prostate cancer treated with androgen deprivation therapyJ Clin Endocrinol Metab20109512E456E46320881261
   PubMed Web of Science ®Google Scholar
• GreenspanSLCoatesPSereikaSMNelsonJBTrumpDLResnickNMBone loss after initiation of androgen deprivation therapy in patients with prostate cancerJ Clin Endocrinol Metab200590126410641716189261
   PubMed Web of Science ®Google Scholar
• MoroteJOrsolaAAbascalJMBone mineral density changes in patients with prostate cancer during the first 2 years of androgen suppressionJ Urol2006175516791683 discussion 168316600728
   PubMed Web of Science ®Google Scholar
• SmithMRLeeWCBrandmanJWangQBottemanMPashosCLGonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancerJ Clin Oncol200523317897790316258089
   PubMed Web of Science ®Google Scholar
• SmithMRBoyceSPMoyneurEDuhMSRautMKBrandmanJRisk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancerJ Urol20061751136139 discussion 13916406890
   PubMed Web of Science ®Google Scholar
• ShahinianVBKuoYFFreemanJLGoodwinJSRisk of fracture after androgen deprivation for prostate cancerN Engl J Med2005352215416415647578
   PubMed Web of Science ®Google Scholar
• TaylorLGCanfieldSEDuXLReview of major adverse effects of androgen-deprivation therapy in men with prostate cancerCancer2009115112388239919399748
   PubMed Web of Science ®Google Scholar
• Network NCCProstate CancerNCCN Clinical Practice Guidelines in Oncology2015 Available from: http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdfAccessed July 2, 2015
   Google Scholar
• BordeleauLPritchardKILoprinziCLMulticenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivorsJ Clin Oncol201028355147515221060031
   PubMed Web of Science ®Google Scholar
• SiderasKLoprinziCLNonhormonal management of hot flashes for women on risk reduction therapyJ Natl Compr Canc Netw20108101171117920971841
   PubMed Web of Science ®Google Scholar
• LoprinziCLSloanJStearnsVNewer antidepressants and gabapentin for hot flashes: an individual patient pooled analysisJ Clin Oncol200927172831283719332723
   PubMed Web of Science ®Google Scholar
• LoprinziCLBartonDLSloanJAMayo clinic and north central cancer treatment group hot flash studies: a 20-year experienceMenopause2008154 pt 165566018427355
   PubMed Web of Science ®Google Scholar
• SchowDARenferLGRozanskiTAThompsonIMPrevalence of hot flushes during and after neoadjuvant hormonal therapy for localized prostate cancerSouth Med J19989198558579743058
   PubMed Web of Science ®Google Scholar
• KarlingPHammarMVarenhorstEPrevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinomaJ Urol19941524117011738072086
   PubMed Web of Science ®Google Scholar
• QuellaSKLoprinziCLSloanJPilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancerJ Urol199916219810210379749
   PubMed Web of Science ®Google Scholar
• IraniJSalomonLObaRBouchardPMottetNEfficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trialLancet Oncology201011214715419963436
   PubMed Web of Science ®Google Scholar
• FriskJManaging hot flushes in men after prostate cancer – a systematic reviewMaturitas2010651152219962840
   PubMed Web of Science ®Google Scholar
• SmithJAJrA prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostateJ Urol199415211321348201642
   PubMed Web of Science ®Google Scholar
• EatonACMcGuireNCyproterone acetate in treatment of postorchidectomy hot flushes. Double-blind cross-over trialLancet198328363133613376139671
   PubMed Web of Science ®Google Scholar
• AtalaAAminMHartyJIDiethylstilbestrol in treatment of postorchiectomy vasomotor symptoms and its relationship with serum follicle-stimulating hormone, luteinizing hormone, and testosteroneUrology19923921081101736500
   PubMed Web of Science ®Google Scholar
• LoprinziCLMichalakJCQuellaSKMegestrol acetate for the prevention of hot flashesN Engl J Med199433163473528028614
   PubMed Web of Science ®Google Scholar
• FriskJSpetzACHjertbergHPeterssonBHammarMTwo modes of acupuncture as a treatment for hot flushes in men with prostate cancer – a prospective multicenter study with long-term follow-upEur Urol200955115616318294761
   PubMed Web of Science ®Google Scholar
• FilshieJBoltonTBrowneDAshleySAcupuncture and self acupuncture for long-term treatment of vasomotor symptoms in cancer patients – audit and treatment algorithmAcupunct Med200523417118016430125
   PubMedGoogle Scholar
• RuddyKJGiobbie-HurderAGiordanoSHQuality of life and symptoms in male breast cancer survivorsBreast201322219719923313328
   PubMed Web of Science ®Google Scholar
• CappelleriJCRosenRCThe Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experienceInt J Impot Res200517430731915875061
   PubMed Web of Science ®Google Scholar
• KiplingMRalphJECallananKPsychological impact of male breast disorders: literature review and survey resultsBreast Care201491293324803884
   PubMed Web of Science ®Google Scholar
• FarrellEBorstelmannNMeyerFPartridgeAWinerERuddyKMale breast cancer networking and telephone support group: a model for supporting a unique populationPsychooncology201423895695824700635
   PubMed Web of Science ®Google Scholar
• Network NCCSurvivorship. NCCN Clinical Practie Guidelines in Oncology2015 Available from: http://www.nccn.org/professionals/physician_gls/pdf/survivorship.pdf
   Google Scholar
• CardinaleDColomboABacchianiGEarly detection of anthracycline cardiotoxicity and improvement with heart failure therapyCirculation2015131221981198825948538
   PubMed Web of Science ®Google Scholar
• NevasaariKHeikkinenMTaskinenPJTamoxifen and thrombosisLancet19782809694694781964
   PubMed Web of Science ®Google Scholar
• LiptonAHarveyHAHamiltonRWVenous thrombosis as a side effect of tamoxifen treatmentCancer Treat Rep19846868878896733701
   PubMedGoogle Scholar
• DeitcherSRGomesMPThe risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic reviewCancer2004101343944915274057
   PubMed Web of Science ®Google Scholar
• FisherBCostantinoJPWickerhamDLTamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJ Natl Cancer Inst19989018137113889747868
   PubMed Web of Science ®Google Scholar
• PowlesTEelesRAshleySInterim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialLancet19983529122981019672274
   PubMed Web of Science ®Google Scholar
• VeronesiUMaisonneuvePCostaAPrevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention StudyLancet1998352912293979672273
   PubMed Web of Science ®Google Scholar
• WellsPSForsterAJThrombolysis in deep vein thrombosis: is there still an indication?Thromb Haemost200186149950811487040
   PubMed Web of Science ®Google Scholar
• PrandoniPLensingAWCogoAThe long-term clinical course of acute deep venous thrombosisAnn Intern Med19961251178644983
   PubMed Web of Science ®Google Scholar
• GoldhaberSZPulmonary embolismN Engl J Med19983392931049654541
   PubMed Web of Science ®Google Scholar
• OgerEIncidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d’Etude de la Thrombose de Bretagne OccidentaleThromb Haemost200083565766010823257
   PubMed Web of Science ®Google Scholar
• AndersonFAJrWheelerHBGoldbergRJA population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT StudyArchives of Internal Medicine199115159339382025141
   PubMedGoogle Scholar
• SilversteinMDHeitJAMohrDNPettersonTMO’FallonWMMeltonLJ3rdTrends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based studyArch Intern Med199815865855939521222
   PubMed Web of Science ®Google Scholar
• HeitJAEpidemiology of Venous Thromboembolism. Nature reviewsCardiology20151246447426076949
   PubMed Web of Science ®Google Scholar
• NaessIAChristiansenSCRomundstadPCannegieterSCRosendaalFRHammerstrømJIncidence and mortality of venous thrombosis: a population-based studyJ Thromb Haemost20075469269917367492
   PubMed Web of Science ®Google Scholar
• SerraRBuffoneGPerriPRenneMAmatoBde FranciscisSMale breast cancer manifesting as cephalic vein thrombosisAnn Vasc Surg2013278e9e1123988541
   PubMed Web of Science ®Google Scholar